USFDA issues CRL for proposed biosimilar Pegfilgrastim: Biocon News News / News 6 years ago 485 Views comments This product is a part of the biosimilars portfolio being developed jointly by Biocon and Mylan. "The US Food and Drug Administration has issued a CRL... Read more
News Positive sentiment for pharma stocks lifts Cipla 4%; UBS maintains buy News / News - 6 years ago
News Nifty to open negative, remain under pressure below 10000: Stewart Mackertich News / News - 6 years ago
News Not possible to stop suicide attacks, security response more important: BSF DG News / News - 6 years ago
Comments